Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - PERCEPTIVE ADVISORS LLC
Last Updated 
20-Mar-17
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

PERCEPTIVE ADVISORS LLC: Declared Holdings
Company/RelationshipReportedShares  Ownership
AcelRx Pharmaceuticals, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ACRX
(historical quotes, profile, other insiders)
29-Sep-165,386,410  Indirect
Aldeyra Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqCM:ALDX
(historical quotes, profile, other insiders)
14-Feb-172,589,451  Indirect
Amicus Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:FOLD
(historical quotes, profile, other insiders)
30-Dec-1616,293,847  Indirect
VBI Vaccines, Inc.
Beneficial Owner (10% or more)
NasdaqCM:VBIV
(historical quotes, profile, other insiders)
6-Dec-166,213,314  Indirect
Versartis, Inc.
Beneficial Owner (10% or more)
NasdaqGS:VSAR
(historical quotes, profile, other insiders)
13-Feb-174,228,563  Indirect

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
14-Feb-17 *893,025ALDX Purchase at $4.50 per share.
(Cost of $4,018,612)
13-Feb-17 *59,133VSAR Purchase at $15.51 per share.
(Cost of $917,152)
10-Feb-17 *34,883VSAR Purchase at $14.94 per share.
(Cost of $521,152)
9-Feb-17 *41,211VSAR Purchase at $14.27 per share.
(Cost of $588,080)
8-Feb-17 *104,612VSAR Purchase at $13.51 per share.
(Cost of $1,413,308)
30-Dec-16 *94,750VSAR Purchase at $14.66 per share.
(Cost of $1,389,035)
30-Dec-16 *94,750FOLD Purchase at $4.96 per share.
(Cost of $469,960)
29-Dec-16 *47,375VSAR Purchase at $14.37 per share.
(Cost of $680,778)
29-Dec-16 *94,750FOLD Purchase at $4.85 per share.
(Cost of $459,537)
28-Dec-16 *47,375FOLD Purchase at $4.91 per share.
(Cost of $232,611)
23-Dec-16 *85,275FOLD Purchase at $4.72 - $4.92 per share.
(Cost of about $411,000)
22-Dec-16 *189,500FOLD Purchase at $4.51 per share.
(Cost of $854,645)
6-Dec-16 *3,383,955VBIV Purchase at $3.05 per share.
(Cost of $10,321,062)
1-Dec-16 *13,223,947FOLD Statement of Ownership
29-Sep-16 *97,200ACRX Sale at $3.88 - $3.88 per share.
(Proceeds of about $377,000)
28-Sep-16 *3,797,419VSAR Statement of Ownership
28-Sep-16 *119,300ACRX Sale at $3.96 - $3.96 per share.
(Proceeds of about $472,000)
15-Sep-16 *392,850ACRX Sale at $3.63 - $3.73 per share.
(Proceeds of about $1,446,000)
25-Aug-16 *1,100,000FOLD Sale at $6.81 per share.
(Proceeds of $7,491,000)
26-May-16 *700,000ALDX Purchase at $5 per share.
(Cost of $3,500,000)
18-Nov-15 *42,300ACRX Sale at $5.35 - $5.35 per share.
(Proceeds of about $226,000)
17-Nov-15 *133,900ACRX Sale at $5.36 - $5.36 per share.
(Proceeds of about $718,000)
6-Nov-15 *17,100ACRX Sale at $4.47 - $4.47 per share.
(Proceeds of about $76,000)
5-Nov-15 *75,000ACRX Sale at $4.62 - $4.62 per share.
(Proceeds of about $347,000)
28-Oct-15 *45,100ALDX Purchase at $6.50 - $6.5 per share.
(Cost of about $293,000)
26-Oct-15 *50,000ALDX Purchase at $6.46 - $6.46 per share.
(Cost of about $323,000)
22-Oct-15 *18,020ALDX Purchase at $6.47 - $6.47 per share.
(Cost of about $117,000)
20-Oct-15 *37,145ALDX Purchase at $6.30 - $6.44 per share.
(Cost of about $237,000)
19-Oct-15 *1,090,193ALDX Statement of Ownership
7-Oct-15 *50,000FOLD Purchase at $6.27 - $6.27 per share.
(Cost of about $314,000)
6-Oct-15 *250,000FOLD Purchase at $6.34 - $6.65 per share.
(Cost of about $1,624,000)
5-Oct-15 *500,000FOLD Purchase at $6.76 - $6.85 per share.
(Cost of about $3,403,000)
9-Sep-15 *310,000ACRX Sale at $4.18 - $4.18 per share.
(Proceeds of about $1,296,000)
    * Indicates that some (or all) shares are held indirectly (e.g. in a trust, by a spouse, etc.)



EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2017 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?